Cooper Companies
The Cooper Companies, Inc. (Nasdaq: COO) is a global medical device company operating through CooperVision and CooperSurgical. CooperVision develops, manufactures and markets contact lenses for wearers worldwide, including single-use, two-week and monthly lenses for vision correction, myopia management and specialty… From the company’s description.
In fiscal 2025, Cooper Companies reported revenue of $4.09B, up 5.1% from fiscal 2024, and net income of $374.90M. Its operating margin was 16.7%, and operations generated $796.10M in cash. Over the twelve months to Jul 31, 2026, revenue was $4.24B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Cooper Companies does
In the company’s own words
The Cooper Companies, Inc. (Nasdaq: COO) is a global medical device company operating through CooperVision and CooperSurgical. CooperVision develops, manufactures and markets contact lenses for wearers worldwide, including single-use, two-week and monthly lenses for vision correction, myopia management and specialty eye care. Its products address conditions including astigmatism and presbyopia and are sold under brands such as Biofinity, MyDay, clariti 1 day and MiSight. CooperSurgical provides products and services in fertility and women’s health to health care professionals, hospitals, surgery centers, medical offices, fertility clinics and consumers. Its offerings include gynecological and obstetric devices, contraception, newborn cord blood and tissue storage, IVF products, donor gametes, cryostorage and genomic services; brands include Paragard. The two businesses are the company’s reportable segments. Cooper sells products in more than 130 countries and its products and services reach over 50 million people annually. Its website is www.coopercos.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- SAN RAMON, CA
- Fiscal year end
- October
- CIK
- 711404
- SIC
- 3851
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Cooper Companies — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Cooper Companies · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Cooper Companies’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Cooper Companies and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Cooper Companies's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Cooper Companies's last four quarterly filings that the numbers alone won't show?”